This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Arteriovenous Fistula, Acquired후천성 동정맥루

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: I77.0 (arteriovenous fistula, acquired) | Special Copayment Reduction: V191 (special copayment reduction for cerebrovascular disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsAcquired arteriovenous fistula, acquired AV shunt, traumatic AVF, iatrogenic AVF
C. Adult onsetOccurs mainly in adults from acquired causes such as trauma, vascular procedures and infection; it can appear at any age, but with the increase in vascular procedures, iatrogenic arteriovenous fistula is more frequent in people in their 40s–70s.
1. HistoryUnderstanding of arteriovenous circulation deepened after William Harvey in the 17th century, and in the late 19th century Nicoladoni systematically described traumatic AVF.
2. CausesMajor causes include trauma (gunshot, stab and blunt injuries), iatrogenic causes (vascular procedures, biopsy, catheter insertion), rupture of infectious aneurysms and tumor invasion.
3. GeneticsBecause it is acquired, genetic predisposition is not direct, but in patients with connective tissue diseases (EDS, Marfan syndrome) the risk of AVF increases due to vessel wall fragility.
4. General epidemiologyEstimated incidence about 1–2 per 100,000 population; the frequency of iatrogenic arteriovenous fistula is rising with the growing number of endovascular interventions.
5. PathophysiologyAn artery and vein connect directly, bypassing capillary resistance, leading to increased blood flow, venous hypertension and increased cardiac output.
6. SymptomsA local pulsatile mass, pain, swelling, heart failure symptoms (dyspnea, fatigue) and distal ischemic symptoms may appear.
7. SignsA continuous bruit on auscultation (machinery murmur), Branham sign (bradycardia when the fistula is compressed) and a thrill at the lesion site are characteristic.
8. ScreeningDoppler ultrasound is the first-line screening test; it confirms high-velocity flow and arterialization of the vein.
9. DiagnosisCT angiography, MR angiography and digital subtraction angiography (DSA) confirm the anatomical location and flow characteristics of the fistula.
10. TreatmentObservation, ultrasound-guided compression, catheter embolization (coils, stents), and surgical ligation or excision are chosen according to size and location.
11. PrognosisGood prognosis with early treatment; if left untreated for a long time, high-output heart failure and complications of venous hypertension may develop.
12. PreventionPrecise anatomical access and ultrasound guidance during vascular procedures, and adequate hemostasis after the procedure, are key to preventing iatrogenic AVF.
13. ReferencesTanner NC et al. Acquired arteriovenous fistula: a review of haemodynamic changes and their clinical consequences … and 9 other papers

1. History

Clinical interest in arteriovenous fistula began in earnest when William Harvey established the theory of blood circulation in the 17th century. In 1628, in Exercitatio Anatomica de Motu Cordis et Sanguinis, Harvey demonstrated that arteries and veins operate as separate pressure systems, and researchers thereafter began to focus on the pathophysiological changes that appear when the two vascular systems are abnormally connected.

In the 19th century, descriptions of traumatic arteriovenous fistula accumulated in the surgical literature. In 1875 the Austrian surgeon Carl Nicoladoni systematically described arteriovenous fistula on the basis of venous pulsation and arterialized venous blood, and recorded the finding that compressing the fistula with a finger lowers the heart rate. This phenomenon later came to be called the Branham sign or the Nicoladoni–Branham sign. William Halsted contributed to standardizing surgical ligation in the 1890s, and through the era of the world wars, as arteriovenous fistulas from gunshot and shrapnel wounds increased sharply, interest from military medicine grew.

In the early 20th century, Matas and Elkin each developed surgical approaches to limb arteriovenous fistulas. In the 1940s–1950s, during World War II, traumatic arteriovenous fistulas were observed in many combat casualties, and this prompted Shumacker, Hughes and others to introduce vascular reconstruction, reporting results superior to simple ligation. With advances in angiography, from the 1950s onward it became possible to determine the anatomical location of the fistula precisely before surgery.

In the 1960s–1970s, as hemodialysis became widespread, arteriovenous fistulas began to be created intentionally for dialysis, and after Brescia and Cimino described the radial wrist arteriovenous fistula (Brescia–Cimino fistula) in 1966, the medical importance of iatrogenic arteriovenous fistula was newly highlighted. On the other hand, as interventional procedures such as renal biopsy, coronary angiography and peripheral arterial intervention increased rapidly, the incidence of unintentional iatrogenic arteriovenous fistula also rose.

In the 21st century, advances in Doppler ultrasound, CT angiography, MR angiography and digital subtraction angiography (DSA) have greatly improved the accuracy of noninvasive diagnosis of fistulas, and catheter-based embolization and stenting have become established alternatives to surgery and are now recognized as standard treatment options.


2. Causes

Acquired arteriovenous fistula arises through various mechanisms and is broadly classified by traumatic, iatrogenic, infectious and neoplastic causes.

Traumatic causes occur when an adjacent artery and vein are injured simultaneously by gunshot wounds, stab wounds, blunt trauma, fractures and the like, forming a direct connection. Penetrating wounds are particularly likely to cause arteriovenous fistulas in areas where artery and vein lie close together, and the neck (cervical arteriovenous fistula), thigh (femoral arteriovenous fistula) and abdominal vessels are common sites. Vascular injury from gunshot wounds sometimes forms a fistula not immediately but with delay, during resorption of a perivascular hematoma, so it may be diagnosed weeks to months later.

Iatrogenic causes are the fastest-growing category of causes in modern medicine and include percutaneous vascular access, renal or liver biopsy, angioplasty, arterial catheter insertion, orthopedic surgery and laparoscopic surgery. The incidence of femoral arteriovenous fistula after coronary intervention via the femoral artery is reported at about 0.1–0.9%; some of these close spontaneously, but many require treatment.

Among infectious causes, a bacterial aneurysm (mycotic aneurysm) may erode and rupture into an adjacent vein, forming a fistula. Infectious aneurysms of the abdominal aorta and mesenteric vessel infections by intestinal bacteria have rarely been reported.

Neoplastic causes are cases in which metastatic or primary perivascular tumors invade the vessel wall and form an arteriovenous communication, as described in hemangioblastoma and renal cell carcinoma. In addition, delayed arteriovenous fistulas due to vascular injury after radiation therapy and spontaneous fistulas have rarely been reported.


3. Genetics

Because acquired arteriovenous fistula is essentially an acquired disease, no specific single gene mutation is a direct cause. However, it is well known that certain genetic backgrounds increase susceptibility to developing arteriovenous fistula.

In Ehlers-Danlos syndrome (EDS), especially the vascular type (vascular EDS, vEDS), mutations in the COL3A1 gene cause defective type III collagen synthesis, markedly increasing the structural fragility of the vessel wall. In this patient group, arteriovenous fistula can develop from minor trauma or vascular procedures alone, and the risk of unexpected vascular rupture and arteriovenous fistula persists throughout life.

In Marfan syndrome, FBN1 gene mutations cause defective fibrillin-1 protein, and the media of the aorta and major vessels is weakened, raising the risk of vascular complications. Immune and inflammatory vascular diseases such as polyarteritis nodosa can also damage the vessel wall and promote secondary arteriovenous fistula formation.

Variants in genes regulating vascular smooth muscle cell proliferation and endothelial function—NOTCH3, ACTA2, SMAD3 and others—have also been reported to be associated with vascular fragility, but further research is needed on whether they are directly involved in the formation of acquired arteriovenous fistula. Hereditary hemorrhagic telangiectasia (HHT) produces arteriovenous malformations of the lung, liver and brain due to ENG and ACVRL1 mutations, but it belongs more closely to the category of congenital vascular anomalies.

Overall, genetic factors in acquired arteriovenous fistula act as "background risk factors," and actual fistula formation always requires an environmental trigger (trauma, procedures, infection, etc.). Genetic testing is performed selectively in patients suspected of having a connective tissue disease, which helps in developing strategies to prevent recurrence.


4. General epidemiology

The exact prevalence of acquired arteriovenous fistula is difficult to determine, because when symptoms are mild or the fistula closes spontaneously, a diagnosis is often never made. Traumatic arteriovenous fistula shows high incidence in regions with a high frequency of penetrating trauma—especially areas with frequent firearm incidents and traffic accidents. In war or conflict zones, arteriovenous fistulas from gunshot wounds account for an important proportion of vascular injuries.

Iatrogenic arteriovenous fistula is the fastest-growing type in modern medicine. The incidence of arteriovenous fistula after cardiac catheterization via the femoral artery is reported variously in the literature at 0.1–1.5%. With the shift to radial artery access, femoral access arteriovenous fistulas have decreased somewhat, but because of more complex interventions and greater use of large-bore catheters, the absolute number of cases remains considerable. The incidence of renal arteriovenous fistula after renal biopsy is reported at about 1–18% even with ultrasound guidance; most are asymptomatic, but clinically significant bleeding occurs in about 0.5–1%.

By sex, traumatic arteriovenous fistula is markedly more common in men (owing to differences in exposure to trauma), while sex differences in iatrogenic arteriovenous fistula vary with the characteristics of the patients undergoing procedures. By age, traumatic fistulas are relatively more common in young men and iatrogenic ones in people in their 50s–70s, who undergo procedures more often. Geographic and socioeconomic factors affect incidence, with iatrogenic fistulas tending to be more common in high-income countries and traumatic ones in low-income countries.


5. Pathophysiology

The core pathophysiology of acquired arteriovenous fistula is an abnormal direct connection between the high-pressure arterial system and the low-pressure venous system. Normally, blood flowing from the arteries through the capillary network to the veins passes with a large pressure drop due to the high resistance of the capillaries, but when an arteriovenous fistula forms, this resistive structure is bypassed and high-pressure flow enters the vein directly.

This triggers the following cascade of hemodynamic changes. First, venous hypertension: as arterial blood flows directly into the vein, venous pressure rises, leading to venous dilatation, varicose veins, peripheral edema and tissue ischemia. Second, distal ischemia: as part of the arterial flow is diverted through the fistula, a steal phenomenon occurs in which tissue blood supply distal to the fistula decreases. Third, increased cardiac output: to compensate for reduced systemic vascular resistance, the heart pumps out more blood, and with a large chronic arteriovenous fistula this can progress to high-output cardiac failure.

At the molecular level, endothelial cells sense increased wall shear stress (WSS) and increase nitric oxide (NO) production, leading to vasodilation and remodeling. In the vein wall, the inflowing high-pressure flow causes intimal hyperplasia and medial hypertrophy, so the vein becomes arterialized. In the long term it can progress to an aneurysmal fistula.


6. Symptoms

The symptoms of acquired arteriovenous fistula vary greatly with the size, location and duration of the fistula. Small fistulas may be asymptomatic and found incidentally, but moderate or larger fistulas produce various local and systemic symptoms.

The most characteristic local symptom is a pulsatile mass at the fistula site, and a thrill is often felt on palpation. Increased skin temperature, redness and venous dilatation around the fistula may be observed, and with chronicity varicosities and skin ulcers develop. Steal symptoms such as coldness, pallor, sensory disturbance and muscle weakness due to distal ischemia may also appear.

Common systemic symptoms are palpitations, exertional dyspnea and fatigue due to increased cardiac output; with large fistulas, dyspnea appears even at rest and typical symptoms of heart failure develop. Chronic fistulas may show heart sound changes similar to the Osler phenomenon.

As site-specific symptoms, cervical arteriovenous fistulas can cause headache, tinnitus (pulsatile tinnitus) and orbital bruits; renal arteriovenous fistulas cause hematuria, hypertension and abdominal bruits; and aortocaval fistulas (abdominal aorta–inferior vena cava) cause abrupt heart failure symptoms and abdominal bruits. Spinal epidural arteriovenous fistulas can cause symptoms of progressive myelopathy.


7. Signs

Physical examination findings are very important in diagnosing arteriovenous fistula, and characteristic signs are key diagnostic clues.

The Branham sign (or Nicoladoni-Branham sign) is the phenomenon in which the heart rate decreases (bradycardia) and blood pressure rises when the fistula is occluded by compressing it with a finger or compressing the proximal artery. It reflects the hemodynamic change whereby blocking the shunt through the fistula restores systemic vascular resistance and reduces cardiac output. It is more pronounced in large arteriovenous fistulas and has high diagnostic value.

On auscultation, a continuous bruit (continuous machinery murmur) persisting through systole and diastole is heard over the fistula. This murmur characteristically peaks in systole and continues into diastole, distinguishing it from a simple arterial stenosis bruit. When only a systolic murmur is heard, differentiation from an aneurysm or vascular stenosis is needed.

On palpation, a thrill—a vibration felt when the hand is placed over the vessel—is present, and this too is a diagnostic clue. Pulses distal to the lesion may be diminished because of the steal effect of the fistula. With large fistulas, a dynamic heart murmur suggesting a high-output state may be heard on cardiac auscultation, and signs of heart failure such as jugular venous distension, cardiomegaly and pulmonary crackles may appear. In the limb below the lesion, skin pigmentation, lipodermatosclerosis and ulcers suggesting chronic venous insufficiency may be observed.


8. Screening

The test used first in screening for acquired arteriovenous fistula is Doppler ultrasonography. It is noninvasive and fast and allows analysis of flow direction, velocity and waveform without radiation exposure. On color Doppler ultrasonography, an arteriovenous fistula shows the characteristic "yin-yang sign"—swirling, multidirectional flow—together with arterialization of surrounding veins (appearance of arterial waveforms).

Doppler ultrasound of the puncture site has become the standard method of evaluating complications for screening for iatrogenic arteriovenous fistula after vascular procedures. In particular, in patients who have undergone coronary intervention via femoral artery access, immediate Doppler ultrasound is recommended when there is a hematoma, pulsatile pain or an abnormal sound at the access site.

When hematuria is found on urinalysis, renal arteriovenous fistula can be suspected, and in this case renal Doppler ultrasound is suitable for first-line screening. ECG and chest X-ray help evaluate accompanying heart failure, and with large arteriovenous fistulas cardiomegaly and increased pulmonary blood flow may be seen. BNP/NT-proBNP testing can be used to screen for accompanying heart failure by blood test.


9. Diagnosis

When an arteriovenous fistula is suspected on Doppler ultrasound, further imaging is needed for confirmation and treatment planning.

CT angiography (CTA) is currently the most widely used confirmatory test and can define the precise anatomical location and size of the fistula and its feeding arteries and draining veins in three dimensions. It can be acquired quickly and has excellent spatial resolution, making it essential for pretreatment planning. Its drawbacks are radiation exposure and contrast nephrotoxicity.

MR angiography (MRA) can evaluate vascular structure without radiation exposure and is particularly useful for soft tissue evaluation of deep-seated fistulas and head and neck fistulas. Time-resolved MRA (dynamic MRA) is advantageous for confirming the direction of flow over time.

Digital subtraction angiography (DSA) is the standard test, offering the highest resolution and real-time flow assessment, and has the advantage that it can be performed together with endovascular treatment. Because it is invasive, it is performed when CTA/MRA is inconclusive or for combined treatment purposes.

The diagnostic criterion is imaging confirmation of a direct, abnormal flow connection from artery to vein, with arterial waveforms in the vein and early venous filling as key findings. Echocardiography can additionally be performed to evaluate cardiac output and accompanying heart failure.


10. Treatment

Treatment of acquired arteriovenous fistula is individualized according to the fistula's size, location and cause, clinical symptoms and the patient's general condition.

Conservative management is chosen for small iatrogenic arteriovenous fistulas—especially small femoral fistulas arising after cardiac catheterization—a considerable proportion of which (about 30–50%) close spontaneously within a few weeks. During observation, changes in size and hemodynamic effects are monitored with repeated Doppler ultrasound.

Ultrasound-guided compression is a noninvasive method that can be tried first-line for iatrogenic femoral arteriovenous fistula. The fistula site is compressed directly with the ultrasound probe to induce thrombosis, with a success rate of about 60–80% depending on fistula size and the patient's anticoagulation status.

Catheter-based embolization is now the preferred treatment for many arteriovenous fistulas, blocking flow by placing coils, vascular plugs, liquid embolic agents and the like at the fistula through an intravascular catheter. It can be performed for most anatomically accessible fistulas, has the advantages of being possible under local anesthesia without general anesthesia and of rapid recovery. A stent graft is effective for covering the arterial-side opening of fistulas arising from large arteries.

Surgery is chosen when embolization is not possible or has failed, for very large fistulas, or when heart failure or ischemia is severe. The abnormal connection between artery and vein is ligated or excised, and vascular reconstruction is performed. Vascular repair using a graft is sometimes needed.


11. Prognosis

The prognosis of acquired arteriovenous fistula depends greatly on whether it is diagnosed and treated early and on the fistula's location and size. Small iatrogenic arteriovenous fistulas can be cured by spontaneous closure or noninvasive treatment and have a good prognosis. After catheter embolization or surgical treatment, too, hemodynamics normalize and symptoms resolve in most patients.

The prognosis of large arteriovenous fistulas left untreated for a long time can be poor. High-output cardiac failure is the most serious systemic complication: with a large chronic arteriovenous fistula, the heart is continuously overloaded, progressing to myocardial hypertrophy, ventricular dilatation and heart failure. In this case heart failure may not fully recover even after the fistula is closed.

Severe distal ischemia can lead to tissue necrosis and even amputation, and skin ulcers from chronic venous hypertension may also be difficult to heal. The recurrence rate after embolization varies between studies, but retreatment has been reported to be needed in up to 10–20% of fistulas with complex anatomy. Overall, advances in modern endovascular techniques have greatly improved the prognosis of arteriovenous fistula.


12. Prevention

Prevention of acquired arteriovenous fistula should be approached by major cause.

Prevention of iatrogenic arteriovenous fistula is the most important prevention task in modern medicine. Using real-time ultrasound guidance during vascular puncture minimizes injury to perivascular structures and can significantly lower the incidence of iatrogenic arteriovenous fistula. For femoral artery access, accurate puncture of the common femoral artery below the inguinal ligament with a technique that punctures only the anterior wall is recommended. Switching to radial artery access where possible can greatly reduce femoral vascular complications altogether.

Adequate compression hemostasis after the procedure is essential, and the use of a vascular closure device can shorten hemostasis time and reduce the risk of complications. In patients taking anticoagulants, dose optimization at the time of the procedure and close monitoring afterward are needed.

Prevention of traumatic arteriovenous fistula requires a societal approach, such as preventing traffic accidents, industrial accidents and firearm incidents, and when trauma occurs, rapid evaluation of vascular injury and appropriate hemostasis minimize the formation of delayed arteriovenous fistulas. In patients with connective tissue disease, unnecessary vascular procedures should be avoided, and when truly necessary they should be performed by an experienced specialist. Early detection and early treatment through regular vascular ultrasound follow-up are important for preventing complications.


13. References

  1. Tanner NC, da Silva A. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database Syst Rev. 2015;7:CD002786. DOI: 10.1002/14651858.CD002786.pub3. PMID: 26171923.

  2. Arnaoutoglou E, Kokossis D, Matsagkas MI. Arteriovenous fistula: a comprehensive review of complications and surgical management. Vascular. 2019;27(2):151-159. DOI: 10.1177/1708538118798247. PMID: 30175931.

  3. Kelm M. Complications after coronary catheterization and how to treat them. Interv Cardiol Clin. 2020;9(1):13-22. DOI: 10.1016/j.iccl.2019.08.003. PMID: 31753194.

  4. Tessarek J, Frenkel S, Ritter R. Iatrogenic arteriovenous fistula after catheterization: diagnosis and treatment with duplex ultrasound. Eur J Vasc Endovasc Surg. 2012;43(6):727-733. DOI: 10.1016/j.ejvs.2012.02.014. PMID: 22401840.

  5. Kim YW, Kim DI, Kim BM. Pathological mechanisms and therapeutic molecular targets in arteriovenous fistula dysfunction. Int J Mol Sci. 2024;25(17):9437. DOI: 10.3390/ijms25179437. PMID: 39273384.

  6. Goltz JP, Petritsch B, Kirchner J, Hahn D. CT angiography versus duplex ultrasound in the assessment of peripheral arteriovenous fistulae. Rofo. 2010;182(6):500-506. DOI: 10.1055/s-0029-1245282. PMID: 20108176.

  7. Saad NE, Saad WE, Davies MG, et al. Pseudoaneurysms and the role of minimally invasive techniques in their management. Radiographics. 2005;25(Suppl 1):S173-189. DOI: 10.1148/rg.25si055503. PMID: 16227491.

  8. Bazan HA, Le BT, Pisare JE, Saad WE. Endovascular repair of arteriovenous fistulae. Semin Vasc Surg. 2020;33(1-2):75-82. DOI: 10.1053/j.semvascsurg.2020.03.004. PMID: 33561488.

  9. Kasirajan K, Greenberg RK, Clair DG, Ouriel K. Endovascular management of visceral artery aneurysms and arteriovenous fistulas. J Vasc Surg. 2001;34(3):536-543. DOI: 10.1067/mva.2001.116551. PMID: 11533608.

  10. Sinha S, Chandrasekhar P, Bhutani B. High output cardiac failure due to large arteriovenous fistula: a case series and review of literature. Indian Heart J. 2021;73(4):519-522. DOI: 10.1016/j.ihj.2021.05.004. PMID: 34474790.